I saw this presentation of the results of a phase 2 trial with LU-177 PSMA-617 and thought it was well done. I thought this presentation could be helpful to those who are new to this or would just like to know more about the LU-177 treatment.
We'll all know a lot more about LU-177 when we get the results of the VISION trial.
The main difference between the two is LU-177 is a beta emitter and AC-255 is an alpha emitter. Beta particles have much less mass and travel further, doing less damage to the cancer cells. Alpha particles are high energy and short range, ideal for destroying whatever cancer is in their range with double strand DNA breaks. The problem with AC-225 is that the side effects are worse because the salivary glands also put out PSMA so it goes there too. Some centers are using a combination of the two.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.